Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Xiamen Innovax Biotech CO., LTD. (INNOVAX) is a wholly owned subsidiary of Beijing Wantai Biological Pharmaceutical Co., LTD., under the YangShengTang Group. Established in 2005, INNOVAX, has been dedicating to provide high-quantity and affordable innovative vaccine for people in need to combat infectious disease, launched the world’s first Hepatitis E Vaccine--Hecolin® in China in October 2012.

List your booth number for exhibitions, ask us